BR112019002023A2 - prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas - Google Patents

prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas

Info

Publication number
BR112019002023A2
BR112019002023A2 BR112019002023A BR112019002023A BR112019002023A2 BR 112019002023 A2 BR112019002023 A2 BR 112019002023A2 BR 112019002023 A BR112019002023 A BR 112019002023A BR 112019002023 A BR112019002023 A BR 112019002023A BR 112019002023 A2 BR112019002023 A2 BR 112019002023A2
Authority
BR
Brazil
Prior art keywords
vectorized
prevention
treatment
probiotic bacteria
antifungal infections
Prior art date
Application number
BR112019002023A
Other languages
English (en)
Inventor
Mylonakis Eleftherios
Burgwyn Fuchs Helen
Campos Junqueira Juliana
Original Assignee
Rhode Island Hospital
Univ Estadual Paulista/Unesp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhode Island Hospital, Univ Estadual Paulista/Unesp filed Critical Rhode Island Hospital
Publication of BR112019002023A2 publication Critical patent/BR112019002023A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204Probiotics, living bacteria to be ingested for action in the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/165Paracasei
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a invenção refere-se a um método e composições bacterianas para reduzir ou prevenir uma infecção em um tecido do corpo por um micro-organismo fúngico por contato do tecido com uma composição compreendendo uma bactéria lactobacillus paracasei purificada.
BR112019002023A 2016-08-01 2017-07-31 prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas BR112019002023A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662369735P 2016-08-01 2016-08-01
PCT/US2017/044703 WO2018026719A1 (en) 2016-08-01 2017-07-31 Probiotic bacteria-directed prevention or treatment of fungal infection

Publications (1)

Publication Number Publication Date
BR112019002023A2 true BR112019002023A2 (pt) 2019-05-14

Family

ID=61073083

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019002023A BR112019002023A2 (pt) 2016-08-01 2017-07-31 prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas

Country Status (3)

Country Link
US (1) US11478516B2 (pt)
BR (1) BR112019002023A2 (pt)
WO (1) WO2018026719A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11478516B2 (en) 2016-08-01 2022-10-25 Rhode Island Hospital Probiotic bacteria-directed prevention or treatment of fungal infection
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
WO2011007584A1 (ja) * 2009-07-16 2011-01-20 国立大学法人広島大学 口腔内疾患の予防、改善又は治療剤
FR2984352B1 (fr) * 2011-12-16 2018-02-16 Lesaffre Et Compagnie Composition comprenant une biomasse microbienne active
WO2016118738A1 (en) * 2015-01-23 2016-07-28 Intralytix, Inc. Novel shigella bacteriophages and uses thereof
US11478516B2 (en) 2016-08-01 2022-10-25 Rhode Island Hospital Probiotic bacteria-directed prevention or treatment of fungal infection

Also Published As

Publication number Publication date
WO2018026719A1 (en) 2018-02-08
US20190151382A1 (en) 2019-05-23
US11478516B2 (en) 2022-10-25

Similar Documents

Publication Publication Date Title
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
EA202091389A1 (ru) Композиция на основе пробиотиков и её применение
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
PH12019550092A1 (en) Virulence attenuated bacteria based protein delivery
PH12019502725A1 (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
MX2017014020A (es) Terapia antimicrobiana.
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
MX2018003101A (es) Activo de polipeptidos de lisina contra bacterias gram-negativas.
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
BR112014027842A2 (pt) bacteriófago lisina e combinações de antibióticos contra bactérias gram-positivas
BR112015027536A8 (pt) composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente.
MX2021002719A (es) Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos.
PH12019500360A1 (en) Antibiotic compounds
EP3787668C0 (en) PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION
PH12019502341A1 (en) Compositions and methods involving probiotic molecules
BR112018014654A2 (pt) cepa inovadora de bactérias probióticas e composições e usos da mesma
ZA202002093B (en) Antibacterial compounds
BR112019002023A2 (pt) prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
MX2022003871A (es) Composiciones inmunogénicas.
EP3195870A4 (en) Agent for promoting growth of nonpathogenic oral indigenous bacteria or agent for improving oral bacterial flora, and composition for oral use
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.
MX2020012543A (es) Diltiazem para usarse en el tratamiento de infecciones microbianas.
RS57471B1 (sr) Nova probiotička starter kultura za humanu i animalnu primenu

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]